Abstract: Quercetin is a plant flavonoid with several biological activities. This study aimed to describe quercetin effects on contractile and electrophysiological properties of the cardiac muscle as well as on calcium handling. Quercetin elicited positive inotropism that was significantly reduced by propranolol indicating an involvement of the sympathetic nervous system. In cardiomyocytes, 30 lM quercetin increased I Ca,L at 0 mV from À0.95 AE 0.01 A/F to À1.21 AE 0.08 A/F. The membrane potential at which 50% of the channels are activated (V 0.5 ) shifted towards more negative potentials from À13.06 AE 1.52 mV to À19.26 AE 1.72 mV and did not alter the slope factor. Furthermore, quercetin increased [Ca 2+ ] i transient by 28% when compared to control. Quercetin accelerated [Ca 2+ ] i transient decay time, which could be attributed to SERCA activation. In resting cardiomyocytes, quercetin did not change amplitude or frequency of Ca 2+ sparks. In isolated heart, quercetin increased heart rate and decreased PRi, QTc and duration of the QRS complex. Thus, we showed that quercetin activates b-adrenoceptors, leading to increased L-type Ca 2+ current and cell-wide intracellular Ca 2+ transient without visible changes in Ca 2+ sparks.
There is a growing recognition that natural products can be used to prevent or even treat several chronic diseases [1] . Numerous epidemiological reports show that dietary plant food intake is associated with beneficial effects in many cardiovascular disorders. Flavonoids, belonging to the group of phytochemicals, are widely found in fruit and vegetables [2] . One of the most common flavonoids in human diet is quercetin (3, 3 0 ,4 0 ,5,7-pentahydroxyflavone), which occurs in nature in several different chemical forms [2] . It has multiple biological effects such as excellent radical scavenging activity [3] , anti-inflammatory [4] and relaxation of vascular smooth muscle [5] . Quercetin pre-treatment protected against myocardium ischaemia-reperfusion injury by decreasing oxidative stress, repressing inflammatory cascades and inhibiting apoptosis in vivo [6] . During the last years, it has been shown that quercetin inhibits mitochondrial ATPase [7] , sarcoplasmic reticulum ATPase [8] , Na + /K + ATPase [9] and cyclic AMP phosphodiesterases [10, 11] . Cardiovascular effects of flavonoids have already been demonstrated [12] such as reduction in blood pressure [13] and by inducing lipid-lowering effects in the management of dyslipidaemias [14] . Important to note here is that quercetin and 3-methylquercetin were shown to have a positive chronotropic effect on the right guinea-pig atrium through b-adrenergic mechanism [15] , and penta-O-ethylquercetin was shown to induce a rapid and transient fall in arterial blood pressure in rats mainly through inhibition of cardiac cyclic AMP phosphodiesterase [16] . The inotropic response to quercetin and derivatives is not fully understood, and further experiments on the mechanism of action will be needed. Therefore, we decided to investigate in more detail the acute effect of quercetin in isolated cardiomyocytes and atria.
Material and Methods
Chemicals. The following drugs were purchased from Sigma-Aldrich (St. Louis, MO, USA): quercetin, protease type XXIII, porcine pancreas trypsin, insulin, bovine serum albumin, 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES), ethylene-bis (oxyethylenenitrilo)tetraacetic acid (EGTA), caffeine, propranolol, nifedipine, tetraethylammonium (TEA), CsCl, CsOH and penicillin/ streptomycin. Collagenase type II was purchased from Worthington Biochemical Co. (Freehold, NJ, USA). Dimethyl sulphoxide (DMSO), NaCl, KCl, KOH, MgCl 2 , NaHCO 3 , CaCl 2 , NaH 2 PO 4 , NaOH and glucose were acquired from Vetec (Rio de Janeiro, Brazil) or Merck (Darmstadt, Germany). Heparin was acquired from Roche and/or Crist alia (São Paulo, Brazil). Fluo4-AM and Fura2-AM were purchased from Molecular Probes, Inc. (Eugene, OR, USA).
Contraction force in isolated mice left atria. To evaluate the inotropic effect of quercetin, mice were killed by decapitation and left atria mounted in an organ chamber. The preparation was maintained in Krebs-Henseleit (K-H) (in mM: NaCl 120, KCl 5.4, MgCl 2 1.2, NaHCO 3 27, CaCl 2 0.5, Glucose 11, NaH 2 PO 4 2.0, pH 7.4), oxygenated with carbogen mixture (95% O 2 and 5% CO 2 ) and maintained at 29 AE 0.1°C. The atria were stretched to 5 mN and submitted to field stimulation (1 Hz), with suprathreshold pulse (100 V, 1.5 ms) (STIMULATOR SD9 GRASS). Atrial force was recorded using an isometric transducer (GRASS FT03), and the signals were digitalized (512 Hz) (DATAQ DI710, WINDAQ PRO Acquisition) and stored in a computer. To evaluate the contractile response of quercetin, it was dissolved in 100% DMSO and later diluted 10 times in K-H solution [DMSO final concentration was 0.2% and has no effect on force development (data not shown)]. 4 , 10 HEPES, 11 glucose (pH = 7.4) at room temperature. After this, the cells were washed twice using Tyrode. Next, cardiomyocytes were placed in a cover slip coated with laminin (2.5 lg/ml). All measurements were made at room temperature on rod-shaped myocytes, which had regular well-defined striations. Average sarcomere length within the user-determined window was measured using the Ionoptix Ltd software that determines the average periodicity of the Z-line density based on the fast Fourier transform algorithm. Unloaded sarcomere shortening was calculated as the difference between peak systolic length and maximum diastolic length normalized by total sarcomere length. Fluorescence ratios were calibrated using IonOptix instructions, as following: Myocytes were submitted to field stimulation using platinum electrodes and pulse of 15 V (unipolar) and 5-to 10-ms duration.
Experimental protocol is show in fig. 1 L-type Ca 2+ current measurements. Ventricular cardiac myocytes from C57Bl/6J mice were enzymatically isolated as described by [17] . Whole-cell voltage-clamp recordings were obtained at room temperature (22-25°C) using an EPC-9.2 patch-clamp amplifier (HEKA Electronics, Rheinland-Pfalz, Germany). Briefly, equilibration between the pipette solution and intracellular environment was reached after 3-5 min. to achieve proper whole cell access. The recording electrodes had tip resistances of 0.8-1.5 MΩ. Current recordings were low-pass filtered at 2.9 kHz and digitized at 10 kHz before being stored on a computer. Cardiac myocytes presenting a series resistance (Rs) larger than 8 MΩ were discarded from the analysis. Rs compensation was set at 40-50%. To measure L-type Ca 2+ current (I Ca,L ), the composition of internal solution was as follows (in mM): 120 CsCl, 20 TEACl, 5 NaCl, 10 HEPES and 5 EGTA (pH was set to 7.2 using CsOH). Tyrode's solution was used as the bath solution (in mM): 140 NaCl, 5.4 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 10 HEPES and 10 glucose (pH 7.4). To investigate the effects of 30 lM quercetin on I Ca,L , test pre-pulses were elicited from a holding potential of À80 mV to À40 mV for 50 ms (every 10 sec.), which inactivates Na + and T-type Ca 2+ channels. Then, the membrane potential was depolarized to 0 mV for 300 ms to measure peak I Ca,L [18] .
The current-to-voltage relationships were constructed using standard voltage protocols. Steady-state activation curves were fitted with the Boltzmann equation G/G max = 1/{1 + exp[(VÀV 0.5 )/k] where V 0.5 is the voltage at which 50% of the maximum conductance was attained and k is the slope factor.
Intracellular global Ca
2+ transient. Ventricular cardiomyocytes were isolated from C57Bl/6J mice (n = 4) and loaded with 5 lM Fluo4-AM (prepared in DMSO). After 30 min. at room temperature, the cells were washed with an extracellular solution (containing 1.8 mM Ca 2+ ) to remove the excess dye. Cardiomyocytes were pre-incubated with 30 lM of quercetin during 3 min. and submitted to electrical field stimulation (1 Hz), applied through a pair of platinum electrodes. A Meta LSM 510 confocal system (Zeiss GmbH, Jena, Germany) with a 639 oil immersion objective was used for confocal fluorescence imaging. Fluo4-AM was excited at 488 nm (Argon laser), and the emission intensity was measured at 510 nm. For recording Ca 2+ transients, cardiomyocytes were scanned with a 512-pixel line. The scan line was positioned randomly along the longitudinal axis of the cell, although care was taken to avoid crossing the nucleus. Cells were scanned every 1.54 ms, and sequential scans were stacked to create two-dimensional images with time on the x-axis. Digital image processing was performed with IDL programming language (Research Systems, Boulder, CO, USA). The intracellular Ca 2+ levels were reported as F/F 0 , where F 0 is the resting fluorescence.
Ca
2+ Sparks in ventricular myocytes. Spontaneous Ca 2+ sparks were recorded using the same confocal settings used for Ca 2+ transients imaging. During spark recordings, cells are kept in Tyrode's solution under resting conditions (non-stimulated). In heart cells, a 15-sec. field stimulation (1 Hz) is required to load the SR prior to spark recordings. After that, a series of line-scan images (e.g. six sweeps; each sweep image can be 512 pixels 9 1000 lines) were acquired at a rate of 1.54 or 1.92 ms per line. Calcium spark analyses were performed with Sparkmaster plug-in in the platform ImageJ.
Electrocardiography. After 30 min. of heparin administration (1000 I.U., i.p.), the mice were killed and the hearts mounted on a constant-flow aortic perfusion system (8 ml/min) (Langendorff technique). The hearts were perfused with K-H solution that had been previously filtered (0.45 lm), oxygenated (95% O 2 + 5% CO 2 ) and maintained at 34 AE 0.1°C (Haake F3 circulating bath, Berlin, Germany). To record the electrocardiogram (ECG), three electrodes (Ag/AgCl/NaCl 1 M) were placed on the heart to sense electrical signals. Those signals were amplified, digitalized (PowerLab 4/35 ADInstrument, Colorado, USA) and stored in a computer. The biological preparation was allowed to stabilize for 30 min. before perfusion quercetin (30 lM).
Statistical analysis. All results are shown as mean AE S.E.M. of n observations, where n represents the number of animals or isolated cells. The results were analysed by one-way ANOVA followed by Tukey's post hoc test. Where appropriate, Student's t-test (paired or non-paired) was applied. A p value of <0.05 was considered significant.
Results
In mice left atrium, quercetin promoted increase of contractile force. Figure 2A shows traces of atrial force in control situation (Top), and with 10 À5 M (Middle) and 10 À5 M (Bottom) quercetin revealing that it significantly augmented the cardiac contractility. Figure 2B depicts the concentrationeffect curves of quercetin (1 9 10 À7 M to 1 9 10 À3 M) that presented value EC 50 of 3.2 9 10 À5 M (n = 4). Propranolol Taking all data together, we suggest that quercetin increases cardiac contractile force probably by an increase in I Ca,L peak amplitude due to b-adrenoceptor stimulation.
To better explore how quercetin increases I Ca,L density, we decided to investigate the biophysical properties of L-type Ca 2+ channels. Current-voltage (I-V) relationships of I Ca,L were obtained using depolarizing step pulses (300-ms duration) from the holding potential of À80 mV to test potentials between À50 mV and 50 mV, delivered in 10 mV increments. I Ca,L was activated at approximately À40 mV and reached a maximum amplitude at 0 mV. Figure 5A shows representative family of recordings of I Ca,L in control cells (black, top traces) and after exposure to quercetin (grey, bottom traces). As is evident from the I to V relationships ( fig. 5B ), quercetin-modified L-type Ca 2+ channels activated at more negative potentials (grey line), reached a maximum at 0 mV and decreased at higher voltages approaching zero at +50 mV. Figure 5C shows steady-state activation curves in control and in the presence of quercetin. Under control conditions, the analysis of steady-state activation curves revealed that V 0.5 was À13.06 AE Figure 7A shows representative line-scan images of spontaneous Ca 2+ sparks in control conditions and in the presence of 7C ) did not change in the presence of quercetin.
As our results showed that quercetin altered homeostasis of intracellular calcium, and as is known that Ca 2+ is essential for the contractile and electrical conductance properties of the heart, we decided to investigate whether quercetin would be able to promote changes in electrocardiographic recordings. Figure 8A shows the effects of quercetin on the PR interval (PRi). This interval measures the driving time of electrical wave by the atrioventricular node. As can be seen, quercetin (30 lM) shortened the PRi from 41.3 AE 0.08 ms to 38.0 AE 0.43 ms (A, n = 4, p < 0.05). QT interval (QTc) and QRS complex duration were also reduced by quercetin from 98.9 AE 0.21 ms to 73.6 AE 0.6 ms (B; n = 4, p < 0.05) and from 26.7 AE 0.29 ms to 24.2 AE 0.16 ms (C; n = 4, p < 0.05), respectively. Furthermore, quercetin influenced the activity pacemaker increasing heart rate from 217.0 AE 0.54 bpm to 258.1 AE 11.1 bpm (D, n = 4, p < 0.05).
Discussion
We have demonstrated for the first time that the acute positive cardiac inotropic effect of quercetin is related to an increased amplitude of I Ca-L and of cell-wide [Ca 2+ ] i transients.
In the heart, several pathways can be activated to promote sustained increase of cardiac contractility. Among them, we can mention the signalling cascade related to the activation of b-adrenoceptors. The stimulation of these receptors activates GTP-binding protein (Gs) that targets adenylyl cyclase (AC), which increases intracellular cAMP concentration activating cAMP-dependent protein kinase (PKA). PKA, in turn, phosphorylates several functional proteins related to excitationcontraction coupling in cardiac muscle. Activation of L-type Ca 2+ channels and/or ryanodine receptors (RyRs) by PKAdependent phosphorylation leads to changes in sarcoplasmic Ca 2+ concentration.
On the other hand, phospholamban that is an endogenous inhibitor of SR Ca 2+ ATPase (SERCA), once phosphorylated by PKA, relieves its tonic inhibition upon SERCA [19] . This increases SR Ca 2+ uptake rate, speed-up sarcoplasmic Ca 2+ decline during relaxation and favours an increase in SR Ca 2+ content [20] . It was shown in rat heart that quercetin induced inotropic and lusitropic effects that were positive at lower concentrations (<10 nM) and negative at higher concentrations (>100 nM) [21] . It was observed that quercetin-elicited positive inotropism and lusitropism was dependent on b 1 /b 2 -adrenoceptors and was associated with increased intracellular cAMP, while the negative inotropism and lusitropism observed at higher concentrations were dependent on a-adrenoceptor activation [21] .
Another study also verified in rat heart that application of quercetin resulted in positive inotropic and lusitropic effects at very low concentrations (10 À10 to 10 À8 M) and negative inotropic and lusitropic effects at higher concentrations (10 À7 and 10 À6 M) [22] . In the heart, activation of a1-adrenoceptor elicits positive inotropic response by activating the GTP-binding protein (Gq) that activates phospholipase C and increases signalling through IP 3 /Ca 2+ /PKC cascade [23] . On the other hand, activation of a2-adrenoceptor in the heart activates GTP-binding protein (G i ) leading to reduced cardiac contractility [24] . Thus, these data indicate that quercetin cardiodepressant response, evident only at high concentrations, is mediated by activation of a2-adrenoceptors. However, we verified that in mice heart, quercetin (from 10 À7 M to 10 À3 M concentration range) only promoted positive inotropism and that was antagonized by propranolol. We can consider that the diversity in a2-adrenoceptor subtypes, density and location in animals and human beings has led to considerable differences in drug concentration and overall effects of a2-agonists in various species [25] .
To our knowledge, the direct interaction of quercetin with L-type Ca 2+ channel was not investigated in mammalian cardiomyocytes. Then, using patch-clamp technique, we verified that quercetin increased L-type Ca 2+ current density and shifted towards more hyperpolarized membrane potentials, the steady-state activation curve of L-type Ca 2+ channels. Such left shift on steady-state activation curve for the L-Type Ca 2+ current may itself explain the increase in the observed peak Ca 2+ current due to a higher conductance over the same electrochemical gradient. However, a direct effect of quercetin on channel individual conductance and/or its open probability may not be discarded. Interesting to note, the increase in cAMP by sympathetic stimulation is associated with increased probability of Ca 2+ channel openings [26] . Therefore, it would be of great interest to investigate the effects of quercetin on Cav1.2 open probability, a subject for further investigation in [29] . SERCA was stimulated by low quercetin concentrations (<25 lM), which is close to the one we used in the present study. Another study showed that quercetin decreased isoprenaline-induced changes in oxidative stress and inflammatory biomarkers with marked improvement in ECG and histopathologic alterations [30] . As seen so far, quercetin cardiac effects most likely depend on the b-adrenergic pathway. Quercetin increased heart rate suggesting a possible effect on heart pacemaker. Increase in L-type Ca 2+ current density evoked by quercetin can probably promote an acceleration of the diastolic depolarization increasing heart rate. These effects are shared with drugs that provoke activation of the sympathetic system [19] . Quercetin improved electrical drive by the AV node demonstrated by a shortened PRi. This change in PRi can be explained by increased Ca 2+ influx [32] .
The QTc interval reflects the duration of the ventricular action potential and is affected by drugs that alter voltagedependent K + currents [33] . Quercetin decreased QTc showing that it accelerated ventricular repolarization, probably by activating voltage-dependent K + channels. The study by Hou et al. [34] provides support to the latter observation. Indeed, the QRS complex also was decreased by quercetin indicating that it affected the rate of ventricular depolarization suggesting that quercetin modified voltage-dependent Na + channels. It was reported that quercetin promoted inhibition of cardiac voltage-gated Na + channel from recombinant human heart Na v 1.5 channels expressed in tsA201 cells [35] . Quercetin is one of the most common polyphenols belonging to the flavonoid group present in a variety of vegetables and fruits used in regular basis by human population. Estimated concentration of quercetin ranges from 0.1 to 250 mg/ 100 g vegetables and/or fruits [36] . One of the first studies to investigate the potential clinical use of quercetin demonstrated that elderly men consuming 25.9 mg/day of quercetin reduced risk of coronary heart disease [37] . After this study, it was demonstrated that hypertensive subjects administered with 730 mg quercetin/day for 28 days had reduced systolic and diastolic blood pressure [38] . These important studies indicate that quercetin has an important clinical impact on many cardiovascular diseases. In the last years, many research groups have investigated the potential systemic, cellular and molecular mechanisms involved in cardiovascular protection attributed to quercetin. Most results point to a pleiotropic action of quercetin, which is effective in reducing cardiac hypertrophy, infarct heart area, oxidative stress and inflammatory state in animal models of cardiovascular human diseases [39] [40] [41] [42] .
Despite the benefits of quercetin, to our surprise, no study had evaluated in detail the cellular mechanism of quercetin action on cardiomyocytes. Our results clearly demonstrate that quercetin has an isoproterenol-like effect, attributed to b-adrenoceptor activation.
Clinical studies have demonstrated the potential benefits of quercetin in cardiovascular diseases [13] . However, our results indicate that caution should be exercised, especially in subjects that are more sensitive to b-agonists. In our study, 10 lM quercetin had significant chronotropic effect on isolated heart. Additionally, previous studies in rats and pigs demonstrated that after 50 mg/kg of quercetin administration, a significant quercetin concentration was found in heart tissue [43] . Thus, quercetin at low concentrations (in vivo) may have a b-agonist effect and it could induce arrhythmic events in subjects with genetic predisposition. Overall, the prospects are promising, but our results suggest that more studies are necessary to better understand whether quercetin supplementation could be indicated or not to individuals that are more prone to cardiac arrhythmias.
Some limitations of the present study should be considered. We did well-controlled experiments in isolated organ, tissue and cells to describe quercetin effects on cardiac electrophysiology and contractility; however, although with those data it is possible to infer the in vivo cardiac activity of this drug, there are many other variables that should be taken into account when thinking in whole animals. Another important point is that our experiments in isolated cells were carried out at room temperature (~25°C), which is a little bit far from the physiological environment of cardiomyocytes. The direct effect of quercetin on single L-type Ca 2+ channels also requires further studies.
In conclusion, our data demonstrate that quercetin, a flavonoid compound found in many vegetables and fruits, can improve cardiac contractility through increased cell-wide [Ca 2+ ] i transients.
